Not logged in
Share
SaveA randomized controlled trial evaluating the effects of anamorelin in postoperative patients with upper gastrointestinal cancer: protocol for the CLEAR-UP study
Yamashita, Kotaro; Nishio, Kazutaka; Mizutani, Shosuke; Nishimura, Yuki; Tarui, Miho; Sakamoto, Shigeru; Iwasaki, Koji; Hida, Eisuke; Nakai, Shigeto; Hagi, Takaomi; Momose, Kota; Saito, Takuro; Tanaka, Koji; Makino, Tomoki; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Eguchi, Hidetoshi; Doki, Yuichiro
Share
SaveDisease-modifying effect, safety and optimal dose of oral semaglutide tablets for patients with Parkinson's disease (MOST-ABLE study): protocol for a randomised, double-blind, placebo-controlled study
Kimura, Yasuyoshi; Koda, Toru; Kurakami, Hiroyuki; Sakamoto, Shigeru; Iwasaki, Koji; Asai, Kanako; Ge, Lindun; Kato, Hiroki; Tsuboi, Takashi; Matsukawa, Noriyuki; Kano, Osamu; Matsuse, Dai; Tomiyama, Masahiko; Yokoe, Masaru; Nagai, Yoshitaka; Mochizuki, Hideki
Share
Save
Share
SavePotential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
Naganuma, Makoto; Watanabe, Kenji; Motoya, Satoshi; Ogata, Haruhiko; Matsui, Toshiyuki; Suzuki, Yasuo; Ursos, Lyann; Sakamoto, Shigeru; Shikamura, Mitsuhiro; Hori, Tetsuharu; Fernandez, Jovelle; Watanabe, Mamoru; Hibi, Toshifumi; Kanai, Takanori
Share
SaveWeek 2 Symptomatic Response with Vedolizumab as a Predictive Factor in Japanese Anti-TNFα-Naive Patients with Ulcerative Colitis: A post hoc Analysis of a Randomized, Placebo-Controlled Phase 3 Trial
Nagahori, Masakazu; Watanabe, Kenji; Motoya, Satoshi; Ogata, Haruhiko; Kanai, Takanori; Matsui, Toshiyuki; Suzuki, Yasuo; Pinton, Philippe; Ursos, Lyann; Sakamoto, Shigeru; Shikamura, Mitsuhiro; Hori, Tetsuharu; Fernandez, Jovelle; Hibi, Toshifumi; Watanabe, Mamoru
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save